These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 2844224)

  • 41. Characteristics of a (Na+-K+)-ATPase inhibitor in extracts of tea.
    Sagnella GA; MacGregor GA
    Am J Clin Nutr; 1984 Jul; 40(1):36-41. PubMed ID: 6331148
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cardiac glycosides: relationship among active 86Rb uptake, (Na+,K+)-ATPase activity, and inotropy in guinea pig heart.
    Akera T; Ku D; Brody TM
    Recent Adv Stud Cardiac Struct Metab; 1976; 9():337-44. PubMed ID: 130662
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Affinity chromatography for human Na+, K+-ATPase inhibitors in plasma and urine.
    Henning G; Cloix JF; Wainer IW; Pernollet MG; Devynck MA; Meyer P
    Life Sci; 1985 May; 36(18):1787-98. PubMed ID: 2984510
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Modulation of aspartate release by ascorbic acid and endobain E, an endogenous Na+, K+ -ATPase inhibitor.
    Bersier MG; Miksztowicz V; Peña C; Rodríguez de Lores Arnaiz G
    Neurochem Res; 2005 Apr; 30(4):479-86. PubMed ID: 16076019
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Angiotensin-II inhibits Na+/K+ pump in rat adrenal glomerulosa cells: possible contribution to stimulation of aldosterone production.
    Hajnóczky G; Csordás G; Hunyady L; Kalapos MP; Balla T; Enyedi P; Spät A
    Endocrinology; 1992 Mar; 130(3):1637-44. PubMed ID: 1311245
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Isolation and characterization of a sodium pump inhibitor from human plasma.
    Hamlyn JM; Harris DW; Clark MA; Rogowski AC; White RJ; Ludens JH
    Hypertension; 1989 Jun; 13(6 Pt 2):681-9. PubMed ID: 2544519
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Adenosine stimulates NA/K ATPase and prolongs survival in hemorrhagic shock.
    Darlington DN; Gann DS
    J Trauma; 2005 Jan; 58(1):1-6. PubMed ID: 15674142
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Properties of the purified hypothalamic pituitary NA/K-ATPase inhibitor.
    Sancho JM; Garcia-Martin E; Garcia-Robles R; Santirso R; Villa E; Gutierrez-Merino C; Ricote M
    J Cardiovasc Pharmacol; 1993; 22 Suppl 2():S32-4. PubMed ID: 7508022
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Differential properties between an endogenous brain Na+, K(+)-ATPase inhibitor and ouabain.
    Peña C; Rodríguez de Lores Arnaiz G
    Neurochem Res; 1997 Apr; 22(4):379-83. PubMed ID: 9130247
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Inhibition of Na,K-ATPase and sodium pump by protein kinase C regulators sphingosine, lysophosphatidylcholine, and oleic acid.
    Oishi K; Zheng B; Kuo JF
    J Biol Chem; 1990 Jan; 265(1):70-5. PubMed ID: 2152929
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Higher plasma Na+,K+-ATPase inhibitory activity in essential hypertensive patients.
    Vasdev S; Fernandez PG; Longerich L; Gault H
    Can J Cardiol; 1989; 5(5):249-54. PubMed ID: 2547501
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Circulating bufodienolide and cardenolide sodium pump inhibitors in preeclampsia.
    Lopatin DA; Ailamazian EK; Dmitrieva RI; Shpen VM; Fedorova OV; Doris PA; Bagrov AY
    J Hypertens; 1999 Aug; 17(8):1179-87. PubMed ID: 10466474
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Ovine cardiac Na,K-ATPase: isolation by means of selective solubilization in Lubrol and the effect of 1 alpha,2 alpha-epoxyscillirosidin on this enzyme.
    Venter PA; Naudé RJ; Oelofsen W; Swan GE
    Int J Biochem Cell Biol; 1997; 29(8-9):1103-12. PubMed ID: 9416006
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Inhibition of protein kinase C, (sodium plus potassium)-activated adenosine triphosphatase, and sodium pump by synthetic phospholipid analogues.
    Zheng B; Oishi K; Shoji M; Eibl H; Berdel WE; Hajdu J; Vogler WR; Kuo JF
    Cancer Res; 1990 May; 50(10):3025-31. PubMed ID: 2159369
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Proton transport catalyzed by the sodium pump. Ouabain-sensitive ATPase activity and the phosphorylation of Na,K-ATPase in the absence of sodium ions.
    Hara Y; Yamada J; Nakao M
    J Biochem; 1986 Feb; 99(2):531-9. PubMed ID: 2422157
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Characterization and partial isolation of ouabain-insensitive Na(+) -ATPase in MDCK I cells.
    De Souza AM; Carvalho TL; Sabino PM; Vives D; Fontes CF; Lopes AG; Caruso-Neves C
    Biochimie; 2007 Nov; 89(11):1425-32. PubMed ID: 17614193
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Purification and properties of endogenous ouabain-like substances from hemofiltrate and adrenal glands.
    Schoner W; Heidrich-Lorsbach E; Kirch U; Ahlemeyer B; Sich B
    J Cardiovasc Pharmacol; 1993; 22 Suppl 2():S29-31. PubMed ID: 7508021
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Increased renal tubular sodium pump and Na+,K+-adenosine triphosphatase in streptozotocin-diabetic rats.
    Ku DD; Meezan E
    J Pharmacol Exp Ther; 1984 Jun; 229(3):664-70. PubMed ID: 6144789
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Measurement of the total concentration of functional Na+, K(+)-pumps in rumen epithelium.
    Kristensen NB; Hansen O; Clausen T
    Acta Physiol Scand; 1995 Sep; 155(1):67-76. PubMed ID: 8553879
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Correlation between catecholamine secretion from bovine isolated chromaffin cells and [3H]-ouabain binding to plasma membranes.
    Aunis D; García AG
    Br J Pharmacol; 1981 Jan; 72(1):31-40. PubMed ID: 6164427
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.